A role for th2 cytokines in the suppression of CD8+ T cell-mediated graft rejection

Ralph Scully, Stephen P. Cobbold, Andrew L. Mellor, Martin Wissing, Bernd Arnold, Herman Waldmann

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

A major histocompatibility complex (MHC) class I-specific T cell receptor (TCR)-transgenic mouse was used to study classical-type transplantation tolerance in the adult. Engraftment of MHC class I-incompatible bone marrow and tolerance to donor-type skin grafts were obtained using dimethylmyeleran (DMM) as a myeloabiative agent and a non-depleting anti-CD8 monoclonal antibody (mAb) as the sole immunosuppressant. Surprisingly, bone marrow engraftment was facilitated by host CD4+ T cells, a subset normally considered unable to reject class I MHC-incompatible grafts. A combination of mAb to interleukins (IL)-4 and -10 antagonized the 'permissive' effects of host CD4+ T cells, indicating a possible role for Th2-type immunoregulation that can act on CD8+ T cells in this form of transplantation tolerance. The fate of graft-reactive T cells was monitored using anti-clonotypic antibodies. It was observed that bone marrow engraftment then led to peripheral deletion of mAb-blockaded, clonotype+ CD8+ T cells.

Original languageEnglish (US)
Pages (from-to)1663-1670
Number of pages8
JournalEuropean Journal of Immunology
Volume27
Issue number7
DOIs
StatePublished - Jul 1 1997

Fingerprint

Graft Rejection
Major Histocompatibility Complex
Cytokines
Transplantation Tolerance
T-Lymphocytes
Bone Marrow
Monoclonal Antibodies
Transplants
T-Lymphocyte Subsets
Immunosuppressive Agents
T-Cell Antigen Receptor
Interleukin-4
Interleukin-10
Transgenic Mice
Anti-Idiotypic Antibodies
Skin

Keywords

  • Bone marrow transplant
  • CD8 antibody
  • Immune regulation
  • T cell receptor transgenic
  • Tolerance

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Scully, R., Cobbold, S. P., Mellor, A. L., Wissing, M., Arnold, B., & Waldmann, H. (1997). A role for th2 cytokines in the suppression of CD8+ T cell-mediated graft rejection. European Journal of Immunology, 27(7), 1663-1670. https://doi.org/10.1002/eji.1830270711

A role for th2 cytokines in the suppression of CD8+ T cell-mediated graft rejection. / Scully, Ralph; Cobbold, Stephen P.; Mellor, Andrew L.; Wissing, Martin; Arnold, Bernd; Waldmann, Herman.

In: European Journal of Immunology, Vol. 27, No. 7, 01.07.1997, p. 1663-1670.

Research output: Contribution to journalArticle

Scully, R, Cobbold, SP, Mellor, AL, Wissing, M, Arnold, B & Waldmann, H 1997, 'A role for th2 cytokines in the suppression of CD8+ T cell-mediated graft rejection', European Journal of Immunology, vol. 27, no. 7, pp. 1663-1670. https://doi.org/10.1002/eji.1830270711
Scully, Ralph ; Cobbold, Stephen P. ; Mellor, Andrew L. ; Wissing, Martin ; Arnold, Bernd ; Waldmann, Herman. / A role for th2 cytokines in the suppression of CD8+ T cell-mediated graft rejection. In: European Journal of Immunology. 1997 ; Vol. 27, No. 7. pp. 1663-1670.
@article{8956a76e4c62424185d4725f4443534a,
title = "A role for th2 cytokines in the suppression of CD8+ T cell-mediated graft rejection",
abstract = "A major histocompatibility complex (MHC) class I-specific T cell receptor (TCR)-transgenic mouse was used to study classical-type transplantation tolerance in the adult. Engraftment of MHC class I-incompatible bone marrow and tolerance to donor-type skin grafts were obtained using dimethylmyeleran (DMM) as a myeloabiative agent and a non-depleting anti-CD8 monoclonal antibody (mAb) as the sole immunosuppressant. Surprisingly, bone marrow engraftment was facilitated by host CD4+ T cells, a subset normally considered unable to reject class I MHC-incompatible grafts. A combination of mAb to interleukins (IL)-4 and -10 antagonized the 'permissive' effects of host CD4+ T cells, indicating a possible role for Th2-type immunoregulation that can act on CD8+ T cells in this form of transplantation tolerance. The fate of graft-reactive T cells was monitored using anti-clonotypic antibodies. It was observed that bone marrow engraftment then led to peripheral deletion of mAb-blockaded, clonotype+ CD8+ T cells.",
keywords = "Bone marrow transplant, CD8 antibody, Immune regulation, T cell receptor transgenic, Tolerance",
author = "Ralph Scully and Cobbold, {Stephen P.} and Mellor, {Andrew L.} and Martin Wissing and Bernd Arnold and Herman Waldmann",
year = "1997",
month = "7",
day = "1",
doi = "10.1002/eji.1830270711",
language = "English (US)",
volume = "27",
pages = "1663--1670",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "7",

}

TY - JOUR

T1 - A role for th2 cytokines in the suppression of CD8+ T cell-mediated graft rejection

AU - Scully, Ralph

AU - Cobbold, Stephen P.

AU - Mellor, Andrew L.

AU - Wissing, Martin

AU - Arnold, Bernd

AU - Waldmann, Herman

PY - 1997/7/1

Y1 - 1997/7/1

N2 - A major histocompatibility complex (MHC) class I-specific T cell receptor (TCR)-transgenic mouse was used to study classical-type transplantation tolerance in the adult. Engraftment of MHC class I-incompatible bone marrow and tolerance to donor-type skin grafts were obtained using dimethylmyeleran (DMM) as a myeloabiative agent and a non-depleting anti-CD8 monoclonal antibody (mAb) as the sole immunosuppressant. Surprisingly, bone marrow engraftment was facilitated by host CD4+ T cells, a subset normally considered unable to reject class I MHC-incompatible grafts. A combination of mAb to interleukins (IL)-4 and -10 antagonized the 'permissive' effects of host CD4+ T cells, indicating a possible role for Th2-type immunoregulation that can act on CD8+ T cells in this form of transplantation tolerance. The fate of graft-reactive T cells was monitored using anti-clonotypic antibodies. It was observed that bone marrow engraftment then led to peripheral deletion of mAb-blockaded, clonotype+ CD8+ T cells.

AB - A major histocompatibility complex (MHC) class I-specific T cell receptor (TCR)-transgenic mouse was used to study classical-type transplantation tolerance in the adult. Engraftment of MHC class I-incompatible bone marrow and tolerance to donor-type skin grafts were obtained using dimethylmyeleran (DMM) as a myeloabiative agent and a non-depleting anti-CD8 monoclonal antibody (mAb) as the sole immunosuppressant. Surprisingly, bone marrow engraftment was facilitated by host CD4+ T cells, a subset normally considered unable to reject class I MHC-incompatible grafts. A combination of mAb to interleukins (IL)-4 and -10 antagonized the 'permissive' effects of host CD4+ T cells, indicating a possible role for Th2-type immunoregulation that can act on CD8+ T cells in this form of transplantation tolerance. The fate of graft-reactive T cells was monitored using anti-clonotypic antibodies. It was observed that bone marrow engraftment then led to peripheral deletion of mAb-blockaded, clonotype+ CD8+ T cells.

KW - Bone marrow transplant

KW - CD8 antibody

KW - Immune regulation

KW - T cell receptor transgenic

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=0030750521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030750521&partnerID=8YFLogxK

U2 - 10.1002/eji.1830270711

DO - 10.1002/eji.1830270711

M3 - Article

C2 - 9247575

AN - SCOPUS:0030750521

VL - 27

SP - 1663

EP - 1670

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 7

ER -